[{"Assets_0_FY_USD":11301400000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.82,"EarningsPerShareDiluted_1_FY_USD":-0.14,"EarningsPerShareDiluted_4_FY_USD":1.07,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":136100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":136000000.0,"EarningsPerShareBasic_1_FY_USD":-0.14,"EarningsPerShareBasic_4_FY_USD":1.07,"StockholdersEquityConverted_0_FY_USD":5804100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":137000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":136500000.0,"StockholdersEquity_0_FY_USD":5803800000.0,"NetIncomeLossConverted_1_FY_USD":-19000000.0,"NetIncomeLossConverted_4_FY_USD":146100000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":387800000.0,"CommonStockSharesConverted_0_FY_shares":136100000.0,"RevenuesConverted_1_FY_USD":1322800000.0,"RevenuesConverted_4_FY_USD":4837400000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200227"}]